Baxter cell harvest in year 6 of the contrac
Ended Awarded Last action
- Contract number
- HHSD2002008249590009
- Awardee
-
Emergent Biodefense Operations Lansing LLC UEI MUM1EGCDWZJ4
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $38,250,000
Award facts
- Opportunity
-
- 2006N08476 Solicitation number
- Contract value 100% obligated
- $38,250,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Cambridge, MA 02139, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $38,250,000 |
About this award
This federal contract award is for BAXTER CELL HARVEST services in year 6 of the contract, awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Emergent Biodefense Operations Lansing LLC, doing business as Emergent Biodefense. The contract has a ceiling value of $38,250,000.00 and was awarded on September 30, 2016, with an ultimate completion date of August 31, 2018. It is a Firm Fixed Price delivery order contract. Emergent Biodefense is a for-profit manufacturer of medical countermeasures and biopharmaceuticals, specializing in vaccines and therapeutics for public health threats, with a focus on biodefense products. The company is the sole manufacturer of BioThrax, the only FDA-licensed vaccine for the prevention of anthrax disease, which is a critical component of the U.S. government's strategic national stockpile. This contract award is not associated with a larger contract vehicle and does not have a set-aside designation.
Quick answers
Who was awarded contract HHSD2002008249590009?
HHSD2002008249590009 was awarded to Emergent Biodefense Operations Lansing LLC by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 30, 2016.
How much is contract HHSD2002008249590009 worth?
The government has obligated $38,250,000 on HHSD2002008249590009.
Is contract HHSD2002008249590009 an order under another contract?
Yes. HHSD2002008249590009 is a delivery order under HHSD200200824959I, an indefinite delivery contract.
Was contract HHSD2002008249590009 competed?
The extent of competition for HHSD2002008249590009 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award